Suspended

Effects of Pregnancy, Age, Drug Use, and Coinfections on HIV Progression in Women

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
Study Aim

This study aims to observe how pregnancy, age, drug use, and coinfections affect the progression of HIV in women.

What is being collected

Data Collection

Who is being recruted

Blood-Borne Infections+11

+ Urogenital Diseases

+ Genital Diseases

Over 18 Years
See all eligibility criteria
How is the trial designed

Natural History

Observing the progression of a disease in untreated individuals in order to understand its typical course and outcomes.
Observational
See protocol details

Summary

Principal SponsorNational Institute of Allergy and Infectious Diseases (NIAID)
Last updated: June 24, 2005
Sourced from a government-validated database.Claim as a partner

The Women's AIDS Cohort Study (WACS) focuses on understanding how various factors like pregnancy, age, drug use, and other infections can influence the progression of HIV in women. This study is specifically designed for women, both HIV-positive and HIV-negative. The goal is to gain insights into how HIV affects women's health, particularly their gynecologic health and reproductive function. This research is crucial as it aims to address the unique challenges faced by women living with HIV, contributing to improved care and treatment strategies. In this observational study, participants are not given any specific treatment. Instead, researchers document and monitor the prevalence and development of HIV infection and related health conditions among the participants. They also observe the impact of HIV on various aspects of gynecologic health, including infections. The study does not involve any direct intervention, but the findings can potentially benefit the medical community and women living with HIV by providing valuable data on the disease's progression and effects.

Principal SponsorNational Institute of Allergy and Infectious Diseases (NIAID)
Last updated: June 24, 2005
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

1250 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Natural History

These studies observe how a disease progresses over time without active treatment. They help researchers understand how conditions typically develop, change, and impact quality of life.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions

Any sex

Biological sex of participants that are eligible to enroll.

Over 18 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Blood-Borne InfectionsUrogenital DiseasesGenital DiseasesCommunicable DiseasesImmunologic Deficiency SyndromesImmune System DiseasesInfectionsRetroviridae InfectionsRNA Virus InfectionsSexually Transmitted DiseasesVirus DiseasesSexually Transmitted Diseases, ViralLentivirus InfectionsHIV Infections

Criteria

No eligibility criteria are available at this time.Please check with the study contact for more details.

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

SUNY - Brooklyn

Brooklyn, United StatesOpen SUNY - Brooklyn in Google Maps
SuspendedOne Study Center